Related Experiment Video
Updated: Mar 13, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Curcumin induces apoptosis in osteosarcoma cells by regulating the glycolytic pathway via the MAPK axis: a
Yi Wang1, Yuxi Zhang2, Yuhan Zhang3
1Faculty of Chinese Medicine and State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, Macau SAR, 999078, China.
Abstract:
This study investigated the mechanism by which curcumin induces apoptosis through glycolytic regulation in osteosarcoma cells (U2OS, MG63) via the MAPK axis. Network pharmacology, protein-protein interaction analysis, and molecular docking were integrated to identify core targets and validate the central role of the MAPK pathway. In vitro, curcumin dose-dependently inhibited cell proliferation (IC50: 32.6 μmol/L in MG63, 37.3 μmol/L in U2OS) and migration, while promoting apoptosis as confirmed by CCK-8, wound healing, flow cytometry, and TUNEL assays. Western blot analysis demonstrated that curcumin significantly upregulated the expression of pro-apoptotic proteins Bax and Cleaved-PARP, as well as phosphorylated P38 and JNK (P-P38, P-JNK), while downregulating the glycolytic enzymes HK2 and PKM2 and the anti-apoptotic protein Bcl-2 (all P < 0.05). Total JNK and P38 levels remained unchanged. The TUNEL assay further confirmed concentration-dependent enhancement of apoptosis, with a marked increase in TUNEL-positive cells at 40 μmol/L. Combined bioinformatic and experimental evidence indicates that curcumin inhibits glycolysis and promotes osteosarcoma cell apoptosis primarily through activation of the JNK/P38 MAPK signaling branch.
Insights
Curcumin inhibits osteosarcoma cell growth by targeting glycolysis and activating the MAPK pathway. This natural compound promotes apoptosis and reduces cell migration, offering potential therapeutic strategies for osteosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Osteosarcoma is a primary bone cancer with limited treatment options.
- Curcumin, a natural compound, exhibits anti-cancer properties.
- The precise mechanisms of curcumin's action in osteosarcoma require further elucidation.
Purpose of the Study:
- To investigate the mechanism of curcumin-induced apoptosis in osteosarcoma cells.
- To explore the role of glycolytic regulation and the MAPK pathway in curcumin's effects.
- To identify key molecular targets of curcumin in osteosarcoma treatment.
Main Methods:
- Network pharmacology, protein-protein interaction analysis, and molecular docking were employed.
- In vitro studies included CCK-8, wound healing, flow cytometry, and TUNEL assays.
- Western blot analysis assessed protein expression levels.
Main Results:
- Curcumin inhibited osteosarcoma cell proliferation and migration.
- Curcumin induced apoptosis by upregulating Bax and Cleaved-PARP and downregulating Bcl-2.
- Curcumin modulated the MAPK pathway by increasing phosphorylated P38 and JNK, while downregulating glycolytic enzymes HK2 and PKM2.
Conclusions:
- Curcumin effectively inhibits osteosarcoma cell growth and induces apoptosis.
- The mechanism involves the downregulation of glycolysis and activation of the JNK/P38 MAPK signaling pathway.
- Curcumin shows promise as a therapeutic agent for osteosarcoma.
Related Concept Videos
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Inhibition of Cdk Activity
The Extrinsic Apoptotic Pathway
Apoptosis

